 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 July 1995 | Volume 123 Issue 2 | Pages 81-88
Objectives: To investigate the point prevalence of the chronic fatigue syndrome and unexplained debilitating chronic fatigue in a community-based sample of persons and to describe demographic, clinical, and psychosocial differences among those with the chronic fatigue syndrome, those with chronic fatigue, and healthy controls.
Design: Prospective cohort study.
Setting: A health maintenance organization in Seattle, Washington.
Participants: A random sample of 4000 members of the health maintenance organization was surveyed by mail for the presence of chronic fatigue.
Measurements: Persons with chronic fatigue were evaluated using a questionnaire that requested information about medical history and fatigue and related symptoms; validated measures of functional status and psychological distress; a physical examination; and standardized blood tests. A structured psychiatric interview was done in persons who appeared to meet the original Centers for Disease Control and Prevention (CDC) criteria for the chronic fatigue syndrome. Participants completed self-report measures at 12 and 24 months. Those with chronic fatigue were reevaluated in person 1 year after study enrollment.
Results: 3066 (77%) of the 4000 members surveyed responded. Chronic fatigue was reported by 590 persons (19%). Of these, 388 (66%) had a medical or psychiatric condition that could account for the fatigue. Of the 74 persons (37%) with chronic fatigue who were enrolled in the study, only 3 met the CDC criteria for the chronic fatigue syndrome. The remaining 71 persons were designated as having chronic fatigue alone. Seventy-four healthy, age- and sex-matched controls who were drawn from the same sample but who denied having chronic fatigue were also studied. Demographic characteristics were similar in persons with the chronic fatigue syndrome, persons with chronic fatigue alone, and controls. Those with the chronic fatigue syndrome or chronic fatigue alone had more frequent cervical and axillary adenopathy, poorer functional status, and greater psychological distress than controls. Women and minorities were not overrepresented among cases with chronic fatigue.
Conclusions: Using different assumptions about the likelihood that persons who did not participate in the study had the chronic fatigue syndrome, the estimated crude point prevalence of the syndrome in this community ranged from 75 to 267 cases per 100 000 persons. The point prevalence of chronic fatigue alone was strikingly higher; it ranged from 1775 to 6321 cases per 100 000 persons.
Author and Article Information
From the University of Washington, Seattle, Washington. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
ARTICLE
Chronic Fatigue and the Chronic Fatigue Syndrome: Prevalence in a Pacific Northwest Health Care System
Requests for Reprints: Dedra Buchwald, MD, Harborview Medical Center, 325 9th Avenue ZA-60, Seattle, WA 98104.
Grant Support: In part by grants RO1 AI26788, RO1 AI27314, and UO1 AI32246 from the National Institute of Allergy and Infectious Diseases; grant RO1 AG08240 from the National Institute of Mental Health; a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (Dr. Buchwald); and the S. Sydney DeYoung Foundation.
This article has been cited by other articles:
|
|
 |
|
  D. S. Ciccone, L. Weissman, and B. H. Natelson Chronic Fatigue Syndrome in Male Gulf War Veterans and Civilians: A Further Test of the Single Syndrome Hypothesis J Health Psychol, May 1, 2008; 13(4): 529 - 536. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Van Houdenhove, L. Verheyen, K. Pardaens, P. Luyten, and P. Van Wambeke Rehabilitation of decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance? Clinical Rehabilitation, December 1, 2007; 21(12): 1121 - 1142. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Niblett, K. E. King, R. H. Dunstan, P. Clifton-Bligh, L. A. Hoskin, T. K. Roberts, G. R. Fulcher, N. R. McGregor, J. C. Dunsmore, H. L. Butt, et al. Hematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue Syndrome Experimental Biology and Medicine, September 1, 2007; 232(8): 1041 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Crofford Violence, Stress, and Somatic Syndromes Trauma Violence Abuse, July 1, 2007; 8(3): 299 - 313. [Abstract] [PDF]
|
|
|
|
|
|
M. G. C. Njoku, L. A. Jason, and S. R. Torres-Harding The Prevalence of Chronic Fatigue Syndrome in Nigeria J Health Psychol, May 1, 2007; 12(3): 461 - 474. [Abstract] [PDF]
|
|
|
|
 |
|
 K. A. Rimes, R. Goodman, M. Hotopf, S. Wessely, H. Meltzer, and T. Chalder Incidence, Prognosis, and Risk Factors for Fatigue and Chronic Fatigue Syndrome in Adolescents: A Prospective Community Study Pediatrics, March 1, 2007; 119(3): e603 - e609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Rief, J. Avorn, and A. J. Barsky Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects Arch Intern Med, January 23, 2006; 166(2): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Smith, E L Fritz, J R Kerr, A J Cleare, S Wessely, and D L Mattey Association of chronic fatigue syndrome with human leucocyte antigen class II alleles J. Clin. Pathol., August 1, 2005; 58(8): 860 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Eriksen and D Bruusgaard Do physical leisure time activities prevent fatigue? A 15 month prospective study of nurses' aides Br. J. Sports Med., June 1, 2004; 38(3): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Farmer, T. Fowler, J. Scourfield, and A. Thapar Prevalence of chronic disabling fatigue in children and adolescents The British Journal of Psychiatry, June 1, 2004; 184(6): 477 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Reyes, R. Nisenbaum, D. C. Hoaglin, E. R. Unger, C. Emmons, B. Randall, J. A. Stewart, S. Abbey, J. F. Jones, N. Gantz, et al. Prevalence and Incidence of Chronic Fatigue Syndrome in Wichita, Kansas Arch Intern Med, July 14, 2003; 163(13): 1530 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jason, A. V. Plioplys, S. Torres-Harding, and K. Corradi Comparing Symptoms of Chronic Fatigue Syndrome in a Community-Based Versus Tertiary Care Sample J Health Psychol, July 1, 2003; 8(4): 459 - 464. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Afari and D. Buchwald Chronic Fatigue Syndrome: A Review Am J Psychiatry, February 1, 2003; 160(2): 221 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Barrett, G. C. Gray, B. N. Doebbeling, D. J. Clauw, and W. C. Reeves Prevalence of Symptoms and Symptom-based Conditions among Gulf War Veterans: Current Status of Research Findings Epidemiol. Rev., December 1, 2002; 24(2): 218 - 227. [Full Text] [PDF]
|
|
|
|
|
|
I. HICKIE, T. DAVENPORT, C. ISSAKIDIS, and G. ANDREWS Neurasthenia: prevalence, disability and health care characteristics in the Australian community The British Journal of Psychiatry, July 1, 2002; 181(1): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Engel Jr., X. Liu, C. Hoge, and S. Smith Multiple Idiopathic Physical Symptoms in the ECA Study:Competing-Risks Analysis of 1-Year Incidence, Mortality, and Resolution Am J Psychiatry, June 1, 2002; 159(6): 998 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Song, L. A. Jason, R. R. Taylor, S. R. Torres-Harding, J. Helgerson, and E. Witter Fatigue Severity among African Americans: Gender and Age Interactions Journal of Black Psychology, February 1, 2002; 28(1): 53 - 65. [Abstract] [PDF]
|
|
|
|
 |
|
 D. J. Clauw Potential Mechanisms in Chemical Intolerance and Related Conditions Ann. N.Y. Acad. Sci., March 1, 2001; 933(1): 235 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Skapinakis, G. Lewis, and H. Meltzer Clarifying the Relationship Between Unexplained Chronic Fatigue and Psychiatric Morbidity: Results From a Community Survey in Great Britain Am J Psychiatry, September 1, 2000; 157(9): 1492 - 1498. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. A. Jason, R. R. Taylor, C. L. Kennedy, K. Jordan, S. Song, D. E. Johnson, and S. R. Torres Chronic Fatigue Syndrome: Sociodemographic Subtypes in A Community-Based Sample Eval Health Prof, September 1, 2000; 23(3): 243 - 263. [Abstract] [PDF]
|
|
|
|
|
|
L. HOSKIN, P. CLIFTON-BLIGH, R. HANSEN, G. FULCHER, and F. GATES Bone Density and Body Composition in Young Women with Chronic Fatigue Syndrome Ann. N.Y. Acad. Sci., May 1, 2000; 904(1): 625 - 627. [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jason, J. A. Richman, A. W. Rademaker, K. M. Jordan, A. V. Plioplys, R. R. Taylor, W. McCready, C.-F. Huang, and S. Plioplys A Community-Based Study of Chronic Fatigue Syndrome Arch Intern Med, October 11, 1999; 159(18): 2129 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Barsky and J. F. Borus Functional Somatic Syndromes Ann Intern Med, June 1, 1999; 130(11): 910 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. McKenzie, A. O'Fallon, J. Dale, M. Demitrack, G. Sharma, M. Deloria, D. Garcia-Borreguero, W. Blackwelder, and S. E. Straus Low-Dose Hydrocortisone for Treatment of Chronic Fatigue Syndrome: A Randomized Controlled Trial JAMA, September 23, 1998; 280(12): 1061 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. DEMITRACK and L. J. CROFFORD Evidence for and Pathophysiologic Implications of Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 684 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Baschetti, A. C. Chester, N. F. Devitt, and A. L. Komaroff Chronic Fatigue Syndrome JAMA, February 11, 1998; 279(6): 431 - 433. [Full Text] [PDF]
|
|
Article
